Engineering GPCR signaling pathways with RASSLs

Bruce R Conklin,Edward C Hsiao,Sylvie Claeysen,Aline Dumuis,Supriya Srinivasan,John R Forsayeth,Jean-Marc Guettier,W C Chang,Ying Pei,Ken D McCarthy,Robert A Nissenson,Jürgen Wess,Joël Bockaert,Bryan L Roth

DOI: https://doi.org/10.1038/nmeth.1232

IF: 48

2008-07-30

Nature Methods

Abstract:We are creating families of designer G protein–coupled receptors (GPCRs) to allow for precise spatiotemporal control of GPCR signaling in vivo. These engineered GPCRs, called receptors activated solely by synthetic ligands (RASSLs), are unresponsive to endogenous ligands but can be activated by nanomolar concentrations of pharmacologically inert, drug-like small molecules. Currently, RASSLs exist for the three major GPCR signaling pathways (Gs, Gi and Gq). We review these advances here to facilitate the use of these powerful and diverse tools.

biochemical research methods